Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD

por Buhl, Roland, Banerji, Donald
Publicado 2012

Future perspectives of anticholinergics for the treatment of asthma in adults and children

por Buhl, Roland, Hamelmann, Eckard
Publicado 2019

Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations

por Glaab, Thomas, Vogelmeier, Claus, Buhl, Roland
Publicado 2010

Guideline-based survey of outpatient COPD management by pulmonary specialists in Germany

por Glaab, Thomas, Vogelmeier, Claus, Hellmann, Andreas, Buhl, Roland
Publicado 2012

Against all odds: anti-IgE for intrinsic asthma?

por Lommatzsch, Marek, Korn, Stephanie, Buhl, Roland, Virchow, Johann Christian
Publicado 2014

Severe and uncontrolled adult asthma is associated with vitamin D insufficiency and deficiency

por Korn, Stephanie, Hübner, Marisa, Jung, Matthias, Blettner, Maria, Buhl, Roland
Publicado 2013

The Prospective Non-Interventional DACCORD Study in the National COPD Registry in Germany: design and methods

por Kardos, Peter, Vogelmeier, Claus, Buhl, Roland, Criée, Carl-Peter, Worth, Heinrich
Publicado 2015

Stratification of eosinophilic asthma patients treated with reslizumab and GINA Step 4 or 5 therapy

por Brusselle, Guy, Canvin, Janice, Weiss, Sivan, Sun, Shawn X., Buhl, Roland
Publicado 2017

Benefits of Tiotropium/Olodaterol Compared with Tiotropium in Patients with COPD Receiving only LAMA at Baseline: Pooled Analysis of the TONADO(®) and OTEMTO(®) Studies

por Buhl, Roland, Singh, Dave, de la Hoz, Alberto, Xue, Wenqiong, Ferguson, Gary T.
Publicado 2020

Asthma exacerbations and worsenings in patients aged 1–75 years with add-on tiotropium treatment

por Mark FitzGerald, J., Hamelmann, Eckard, Kerstjens, Huib A. M., Buhl, Roland
Publicado 2020

Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management

por Kaplan, Alan, FitzGerald, J. Mark, Buhl, Roland, Vogelberg, Christian, Hamelmann, Eckard
Publicado 2020

Chronisch-obstruktive Lungenerkrankung 2021 – die richtige Therapie für den richtigen Patienten

por Olschewski, Horst, Buhl, Roland, Funk, Georg Christian, Valipour, Arschang, Vogelmeier, Claus F.
Publicado 2021

Impact of tiotropium + olodaterol on physical functioning in COPD: results of an open-label observational study

por Sauer, Rüdiger, Hänsel, Michaela, Buhl, Roland, Rubin, Roman A, Frey, Marcel, Glaab, Thomas
Publicado 2016

Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY)...

por Buhl, Roland, Gessner, Christian, Schuermann, Wolfgang, Foerster, Karin, Sieder, Christian, Hiltl, Simone, Korn, Stephanie
Publicado 2015

Efficacy of Tiotropium + Olodaterol in Patients with Chronic Obstructive Pulmonary Disease by Initial Disease Severity and Treatment Intensity: A Post Hoc Analysis

por Ferguson, Gary T., Fležar, Matjaž, Korn, Stephanie, Korducki, Lawrence, Grönke, Lars, Abrahams, Roger, Buhl, Roland
Publicado 2015

Efficacy and safety of tiotropium + olodaterol maintenance treatment in patients with COPD in the TONADO(®) and OTEMTO(®) studies: a subgroup analysis by age

por Ferguson, Gary T, Karpel, Jill P, Clerisme-Beaty, Emmanuelle, Grönke, Lars, Voß, Florian, Buhl, Roland
Publicado 2016

Long-term safety of tiotropium/olodaterol Respimat(®) in patients with moderate-to-very severe COPD and renal impairment in the TONADO(®) studies

por LaForce, Craig, Derom, Eric, Bothner, Ulrich, Kloer, Isabel M, Trampisch, Matthias, Buhl, Roland
Publicado 2018

COPD Assessment Test Changes from Baseline Correlate with COPD Exacerbations: A Longitudinal Analysis of the DACCORD Observational Study

por Kardos, Peter, Vogelmeier, Claus F., Worth, Heinrich, Buhl, Roland, Obermoser, Victoria, Criée, Carl-Peter
Publicado 2020

Long-term safety of tiotropium/olodaterol in older patients with moderate-to-very-severe COPD in the TONADO® studies

por Ferguson, Gary T., Maltais, François, Karpel, Jill, Bothner, Ulrich, Kloer, Isabel, Trampisch, Matthias, Buhl, Roland
Publicado 2020

Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD ‘real world’ study

por Vogelmeier, Claus F., Worth, Heinrich, Buhl, Roland, Criée, Carl-Peter, Gückel, Eva, Kardos, Peter
Publicado 2022